Choosing the analysis population in non-inferiority studies: per protocol or intent-to-treat
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
For superiority trials, the intent-to-treat population (ITT) is considered the primary analysis population because it tends to avoid the over-optimistic estimates of efficacy that results from a per-protocol (PP) population. However, the roles of the ITT population and PP population in non-inferiority studies are not clearly defined as in superiority trials. In this paper, a simulation study is conducted to systematically investigate the impact of different types of missingness and protocol violations on the conservatism or anticonservatism of analyses based on the ITT and the PP population in non-inferiority trials. We find that conservatism or anticonservatism of the PP or ITT analysis depends on many factors, including the type of protocol deviation and missingness, the treatment trajectory (for longitudinal study) and the method of handling missing data in ITT population. The requirement that non-inferiority be shown for both PP and ITT populations does not necessarily guarantee the validity of a non-inferiority conclusion and a sufficiently powered PP analysis is not necessarily powered for ITT analysis. It is important to assess the potential types and rates of protocol deviation and missingness that might occur in a non-inferiority trial and to obtain some prior knowledge regarding the treatment trajectory of the test treatment versus the active control at the design stage so that a proper analysis plan and appropriate power estimation can be carried out. In general, for the types of protocol violations and missingness considered, we find that hybrid ITT/PP analysis, which excludes non-compliant patients as in the PP analysis and properly addresses the impact of non-trivial missing data as in the MLE-based ITT analysis, is more promising by way of providing reliable non-inferiority tests.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RUBIN, D. B. (1976) · Biometrika · doi:10.1093/biomet/63.3.581 · Cited by 9,925
Random-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
Trials to assess equivalence: the importance of rigorous methods: Fig 1
Jones, B., Jarvis, P., Lewis, J. A., & Ebbutt, A. F. (1996) · BMJ · doi:10.1136/bmj.313.7048.36 · Cited by 1,032 · cited 1×
“Sample size computations are performed to ensure su cient numbers of subjects in the PP population and then increased for the ITT population based on the projected protocol violation and withdrawal rate [7].”
MethodStatistical Considerations in the Intent-to-Treat Principle
Lachin, J. M. (2000) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00046-5 · Cited by 652 · cited 1×
“Thus, withdrawal from treatment should not lead to withdrawal from study [8].”
Background
Cited by
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Intention-to-treat concept: A review
Gupta, S. (2011) · Perspectives in Clinical Research · doi:10.4103/2229-3485.83221 · Cited by 1,921
Transfusion Strategies for Patients in Pediatric Intensive Care Units
Lacroix, J., Hébert, P. C., Hutchison, J. S., Hume, H. A., Tucci, M., Ducruet, T., Gauvin, F., Collet, J.-P., Toledano, B. J., Robillard, P., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066240 · Cited by 1,085
Andersson, G., Hesser, H., Veilord, A., Svedling, L., Andersson, F., Sleman, O., Mauritzson, L., Sarkohi, A., Claesson, E., Zetterqvist, V., et al. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.08.022 · Cited by 195
de Zwaan, M., Herpertz, S., Zipfel, S., Svaldi, J., Friederich, H.-C., Schmidt, F., Mayr, A., Lam, T., Schade-Brittinger, C., & Hilbert, A. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.2150 · Cited by 153
The role of intention to treat in analysis of noninferiority studies
Wiens, B. L., & Zhao, W. (2007) · Clinical Trials · doi:10.1177/1740774507079443 · Cited by 72
“Recently a hybrid ITT/PP analysis was proposed for missing data in noninferiority studies [18].”
MethodSloan, D. M., Marx, B. P., Resick, P. A., Young-McCaughan, S., Dondanville, K. A., Straud, C. L., Mintz, J., Litz, B. T., Peterson, A. L., & STRONG STAR Consortium (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.40911 · Cited by 69
Mohr, D. C., Lattie, E. G., Tomasino, K. N., Kwasny, M. J., Kaiser, S. M., Gray, E. L., Alam, N., Jordan, N., & Schueller, S. M. (2019) · Behaviour Research and Therapy · doi:10.1016/j.brat.2019.103485 · Cited by 57
Reinholt, N., Hvenegaard, M., Christensen, A. B., Eskildsen, A., Hjorthøj, C., Poulsen, S., Arendt, M. B., Rosenberg, N. K., Gryesten, J. R., Aharoni, R. N., et al. (2022) · Psychotherapy and Psychosomatics · doi:10.1159/000516380 · Cited by 55
(2023) · International Journal of Exercise Science · doi:10.70252/eerp4920 · Cited by 20
Impact of missing data on type 1 error rates in non-inferiority trials
Yoo, B. (2010) · Pharmaceutical Statistics · doi:10.1002/pst.378 · Cited by 12
Critical assessment of intent-to-treat analyses
Shaya, F. T., & Gu, A. (2007) · Journal of Medical Economics · doi:10.3111/200710171177 · Cited by 8
Metadata
- Authors
- Matilde Sanchez, M., & Chen, X.
- Venue
- Statistics in Medicine
- Publisher
- Wiley
- Published
- 2006
- Volume
- 25
- Issue
- 7
- Pages
- 1169-1181
- ISSN
- 0277-6715 (ISSN-L)
- 1097-0258
- OpenAlex
- W2158968342
- Cited by
- 147
- References
- 4
- FWCI
- 5.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.